Correlation Between Inhibrx and GlycoMimetics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inhibrx and GlycoMimetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and GlycoMimetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and GlycoMimetics, you can compare the effects of market volatilities on Inhibrx and GlycoMimetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of GlycoMimetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and GlycoMimetics.

Diversification Opportunities for Inhibrx and GlycoMimetics

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between Inhibrx and GlycoMimetics is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and GlycoMimetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GlycoMimetics and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with GlycoMimetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GlycoMimetics has no effect on the direction of Inhibrx i.e., Inhibrx and GlycoMimetics go up and down completely randomly.

Pair Corralation between Inhibrx and GlycoMimetics

Given the investment horizon of 90 days Inhibrx is expected to under-perform the GlycoMimetics. But the stock apears to be less risky and, when comparing its historical volatility, Inhibrx is 1.86 times less risky than GlycoMimetics. The stock trades about -0.05 of its potential returns per unit of risk. The GlycoMimetics is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  33.00  in GlycoMimetics on December 1, 2024 and sell it today you would lose (6.00) from holding GlycoMimetics or give up 18.18% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Inhibrx  vs.  GlycoMimetics

 Performance 
       Timeline  
Inhibrx 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Inhibrx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental drivers remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
GlycoMimetics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days GlycoMimetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Inhibrx and GlycoMimetics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inhibrx and GlycoMimetics

The main advantage of trading using opposite Inhibrx and GlycoMimetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, GlycoMimetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GlycoMimetics will offset losses from the drop in GlycoMimetics' long position.
The idea behind Inhibrx and GlycoMimetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated